
The first GLP-1 weight-loss pill has been approved for use in the UK – here is everything you need to know about the medication and its potential side effects.
Semaglutide medication Wegovy has been turned into a once-a-day pill, allowing users looking for weight management an alternative to injectable GLP-1s.
The medication was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) earlier this month, meaning it will soon be available for patients to access with a private prescription.
While there's still a wait to get the Wegovy pill in the UK, it is currently readily available in the US, meaning there are already plenty of first-hand experiences detailing what it's like to take the drug.
Advert
And the results are life-changing.

One woman in the US revealed that she began taking Wegovy in pill form after feeling uncomfortable with the idea of injecting herself, and has already lost over 7kg since starting the medication two months ago.
"I quickly started to notice a difference," Rebecca Walker told MailOnline about her experience using the medication.
"I started losing weight, I could fit into my clothes again, and my energy went back up. I’m running again now."
What are the side effects associated with taking Wegovy in pill form?
The oral form of Wegovy uses the same active ingredient, semaglutide, as the injectable version, with listed side effects including:
- Nausea, diarrhoea, and other gastrointestinal issues
- Fatigue
- Abdominal pain
- Dizziness
- Bloating
- Low blood sugar

Side effects also vary from person to person, with Rebecca revealing that she only suffered mild symptoms after starting the pills.
"For the first couple of days I had an upset stomach," she said. "But it wasn’t anything to worry about."
Meanwhile, another woman using the medication reported dealing with ' mind‑blowing fatigue' and a lack of motivation. However, she added that the side effects decreased as her body adjusted to the medication.
Who is eligible to get Wegovy pills in the UK – and how to get them
Following its approval, the Wegovy pill will be available to adults with a BMI of 30 or above, or a BMI of 27 or above if they have a diagnosed weight-related illness, such as high blood pressure or type 2 diabetes.

The medication is currently only available through private clinics, with Superdrug, ASDA and LloydsPharmacy all advertising the drug. The pills are not currently available through the NHS, with the medication likely to undergo evaluation by the National Institute for Health and Care Excellence (NICE).